Years of experience in the field of Regenerative Medicine have taught us one thing: Safety, Quality, Efficacy and Compliance aren’t only attributes to strive for during the production of human umbilical cord and placental derived products – they’re essential. A.H.S. is proud to partner with a team that combines industry leaders in the field of Regenerative Medicine who share a common goal – harnessing the true science of these powerful tissues, in order to unlock the body’s natural ability to heal.

The Wharton's Jelly product is a connective tissue allograft intended for homologous use, and is intended to replace or supplement missing or damaged tissue directly at the site of a structural defect. Wharton's Jelly is minimally processed to preserve the structural integrity and original characteristics of the connective tissue.

The amniotic membrane allograft is intended for homologous use to cover and protect the recipient's tissues.  This product is minimally manipulated and processed to preserve the original relevant characteristics relating to it's utility as a barrier. These patches can be placed on the wound closure sites after a medical procedure, or directly onto an open wound.